LL37
Typical Dosing Protocols (Research/Compounded Use Only) – LL-37
Common protocol: 100–200 mcg subcutaneously once daily for 10–20 consecutive days. Most users start at 100 mcg daily for the first 5–7 days then increase to 150–200 mcg if tolerated.
Other reported ranges:
Standard: 100–200 mcg daily
Intensive: 200–300 mcg daily (for short periods only)
Cycles: Typically 10–20 days on, followed by a minimum 2–4 week break. Some protocols use 5 days on / 2 days off.
Reconstitution example (for a typical 5 mg vial): Add 2 mL bacteriostatic water (yielding ~2.5 mg/mL).
100 mcg = 0.04 mL (4 units on U-100 insulin syringe)
200 mcg = 0.08 mL (8 units)
Administration: Subcutaneous injection (abdomen or thigh). Some users also apply topically (after reconstitution) for localized skin or wound support.
Dosing is highly individualized based on goals (immune support, antimicrobial, wound healing) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
